Oral Treatment for Opioid-Induced Constipation Approved
DEERFIELD, IL - Lubiprostone, marketed as Amitiza by Sucampo Pharmaceuticals Inc. and its partner Takeda Pharmaceuticals USA Inc., has been approved by the Food and Drug Administration (FDA) as the...
View ArticleAntibiotic Vibativ Now Approved for Treating HABP/VABP
SAN FRANCISCO - The antibiotic Vibativ (telavancin) is now approved to treat patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by Staphylococcus aureus.
View ArticleFirst A1c Test Approved for Diagnosing Diabetes
INDIANAPOLIS, IN - For the first time, the U.S. Food and Drug Administration is allowing marketing of an HbA1c test specifically for diagnosing diabetes.
View ArticleNew Therapies Approved for Metastatic, Unresectable Melanoma
RESEARCH TRIANGLE PARK, NC - Two new therapies, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved for patients with metastatic or unresectable melanoma, according to the Food and Drug...
View ArticleNew Procedures for Navy Pharmacy Save More than $35 Million, Improve Care
FALLS CHURCH, VA - After saving $22 million in Phase One, the Navy Pharmacy Financial Improvement Program has expanded from establishing target inventory levels to refining stock levels based on demand...
View ArticleClosed System Transfer Device Reduces Chemotherapy Drug Waste
Salvaged Drugs Mean $700,000 in Annual Savings at Walter ReedBETHESDA, MD - With increasing shortages of critical chemotherapy drugs - and the funds to buy them — VA pharmacists are constantly looking...
View ArticleNew Therapy Approved for Adults Suffering Major Depressive Disorder
DEERFIELD, IL — Brintellix (vortioxetine) has been approved by the Food and Drug Administration to treat adults with major depressive disorder (MDD).
View ArticleExpanded Options Available for Metastatic Pancreatic Cancer Treatment
SUMMIT, NJ — The approved uses of Abraxane — paclitaxel protein-bound particles for injectable suspension, albumin-bound — have been expanded by the Food and Drug Administration to treat patients with...
View ArticleFirst-in-Class Product Approved for Rosacea-Caused Facial Redness
FT. WORTH, TX — The first treatment for facial erythema in adults caused by rosacea has been approved by the Food and Drug Administration.
View ArticleUniformed Pharmacists Take Half of Next Generation Pharmacist Awards
LAS VEGAS, NV — Of the 30 finalists in this year’s Next Generation Pharmacist awards, 30% worked in military or public health pharmacies, the strongest representation seen in the awards program.
View Article
